http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009538822-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate | 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009538822-A |
titleOfInvention | Treatment of viruses in veins |
abstract | The present invention provides unit dosage forms, kits, and methods useful for the treatment of viral infections. One embodiment of the present invention provides a method of treating a human viral infection (eg, influenza infection), wherein the method comprises an amount of a compound of formula I, II, III, or IV having effective antiviral activity. Or administering a pharmaceutically acceptable salt thereof to a human by an intravenous route. The invention also provides a method of inhibiting neuraminidase in the human body, wherein the method comprises an amount of a compound of formula I, II, III, or IV, or a pharmaceutically acceptable amount thereof, with effective inhibitory activity. Administering salt to the human by an intravenous route. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535820-A |
priorityDate | 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.